Accelerating the future: AI powered pharma innovation

From accelerated drug discovery to precision medicine, life-extending therapies to customised products the future of health is predictive, preventative, and personalised. AI is already accelerating the pace of change, and its potential to reshape the life sciences and heathcare sectors is even greater.

How can life sciences and healthcare organisations unlock and measure the value of AI? How do you address issues like building trust, developing skills and talent, and fostering collaboration across the entire health ecosystem? 

Mishal Patel, Corporate Vice President, AI & Digital Research at Novo Nordisk and Haseeb Ahmad, former President of Novartis Europe joined Deloitte Partner Seb Burnett and Hanno Ronte, and Karen Taylor, Director of the Centre for Health Solutions to discuss these questions and more.

You can view the recording below. 

This event is part of the Life Sciences and Healthcare Predictions 2030 insights series which explores what the future might feel like for different stakeholders in the health ecosystem, the evidence today that informs our views of tomorrow and how AI technologies, specifically GenAI, might help bring the future closer.